tems for getting it done. The two issues of financing and lack of systems are especially relevant for elderly patients, because Medicare pays for few preventive care activities, and because older patients frequently have multiple chronic medical problems that divert medical attention from the prevention agenda. Studies of either reducing financial barriers or improving office systems for preventive care have met with some success, but performance remains suboptimal. [8] [9] [10] [11] [12] [13] No large study has investigated the effects of a combined financial and office systems intervention on preventive care in community practice.
Yet, reimbursement for preventive care is a key element in President Clinton's health security plan14 and other health care reform proposals. It is timely then to consider research on whether and under what circumstances the effectiveness and savings assumed by these plans from the widespread introduction of preventive care in community practices will occur.
Although performance of preventive care begins the chain of events that should lead to improved patient health, performance by itself is not sufficient to guarantee this outcome. For screening tests, the test must first be documented as efficacious in detecting health problems at an early stage, and leading to effective treatment that improves quality of life or reduces mortality. For example, there is strong evidence that Papanicolaou (Pap) smears and clinical breast examinations are effective, and increasing evidence also for fecal occult blood testing and hearing screening; there is indirect evidence of effectiveness for screening for visual acuity problems, incontinence, and depression.
After specific tests have been shown to be effective, the tests must then be applied in practice, and abnormal results recognized, evaluated, and, where indicated, treated. Any break in this chain would result in fewer patients benefiting from the screening test. Most research projects have concerned themselves only with performance of preventive care, and not with later steps in the process.
In 1985, the Health Care Financing Administration (HCFA) funded a demonstration project at the University of North Carolina at Chapel Hill to examine the cost and effectiveness of adding a "package" of preventive care services to Medicare. 15 The demonstration sought to test the effectiveness of a package of preventive services rather than individual procedures for two main reasons. First, elderly people are much more likely than other age groups to have multiple conditions that pose important health risks, so that interventions are less likely to be effective if targeted only on one risk factor or another. Second, there are potential administrative and payment efficiency benefits to offering services in a package as opposed to one at a time.
Project investigators recruited 10 community practices (13 sites) to participate, and added an office systems component to the intervention. This project allowed us to address the aforementioned gaps in the literature for community practices caring for older patients: the effect of a combined financial reimbursement and office systems intervention on performance of preventive procedures and subsequent steps in the preventive chain leading to improved health. We were also able to examine the effect of the intervention on health-related quality of life and health care costs. We tested the hypotheses that the interventions will lead to an increase in coverage of screening procedures, an increase in health-related quality of life, and a decrease in costs. We reasoned that costs would rise for the intervention group during the first few months of the project, as participants became more health conscious and screening programs produced positive findings, and then would gradually decline about 24 months after entry into the demonstration, indicating improved health.
Methods

Practice Characteristics
Ten primary care practices involving 13 locations in central North Carolina participated in the study. Of the ten practices, four were general internal medicine (one an academic clinic, three private practice), three were family practice, and three were community health centers (two staffed primarily by internists and one by family physicians).
Preventive Care Interventions
Financing. The intervention included two components, financial and office system changes. First, physicians received an annual capitated payment from HCFA of $53 for a preventive care visit, defined later, and $47 for a health promotion counseling visit ($100 for both). In May, 1988, reimbursements were increased by 4.27% as an inflation adjustment. These funds were paid to the practice as any other Medicare reimbursement, not separated from other payments for services. Thus, this package of preventive services was free for intervention-group patients.
The preventive-care package (Table 1 ) was negotiated with HCFA. This package included some procedures with known efficacy (e.g., Pap smear and clinical breast examination), and others with uncertain efficacy (e.g., urine analysis, rectal examination, incontinence screening). Other procedures with known efficacy (e.g., mammography) were left out owing to concerns at HCFA with their cost. The preventive care package was carried out largely by nursing personnel, with the exception of a few items The health promotion service package contained a set of procedures and nursing interventions that address important risk factors and premature mortality, institutionalization, and increased disability for older people (Table 2) . Health promotion sessions in this demonstration were conducted in physician offices using an individual counseling strategy that involved the nurse/physician assistant and patient in mutual planning of cognitive, affective, and behavior change. The service was offered to all participants in the appropriate groups semiannually. Three areas (physical activity, nutrition, and stress management/problem solving) were included for all participants, with other areas covered depending on the patient's interest and presence of risk factors. The health promotion nurses were trained in counseling strategies that focused on the setting of personal change goals, altering relevant social and environmental factors in the patient's life, and mobilizing formal and informal community resources. The health promotion intervention was based on risk appraisal and referral, but did not involve short-term follow-up or monitoring of progress toward goals. Nurses followed protocol instructions as to the content of the sessions and suggested goals and interventions. A health promotion session lasted about an hour and was offered every 6 months.
Office Systems. The second component of the intervention affected office systems. Practices were prompted monthly by the re- Owing to recruitment delays, the duration of the intervention was shortened after the start of the study from 4 to 2 years to fit within the funded project period. Within this 2-year period, people who were assigned to the intervention group were eligible to receive two annual preventive-care visits plus four semiannual health promotion visits at their practice. The waiver for services remained in effect until September, 1990, so that subjects in the intervention group who were recruited during the first half of the study were eligible to receive up to two additional years of services. Although we have cost data for the entire period, we do not have patient interview data beyond the 2-year follow-up.
The usual-care (control) group received preventive services as customarily offered by their practice, at prevailing cost and with exact preventive procedures and charges varying among the different practice sites. (At the beginning of this study, pneumococcal vaccination was the only prevention service covered by Medicare. Mammography was not covered during the time of the study, although it is at present.) In lieu of any other tangible benefit, a nominal fee ($5) was paid to participants in the control group to defray costs of transportation to the office for the patient interview.
Evaluation Design
The evaluation was conducted using a randomized, controlled trial design. Randomization occurred within each practice. Although contamination of the control group is sometimes a concern with such a design, it was not an issue here for two reasons: first, the financial intervention involved full Medicare reimbursement to physicians for preventive-care and health promotion packages only for those patients randomized to the intervention group; and second, the office system intervention was in effect only for patients receiving the intervention group. The control group was not identified to the practice. There was no prompting, no form, and no special preventive visit for control-group patients, even though they were cared for by the same physicians as the intervention group.
Once a practice agreed to participate, the names, addresses, and phone numbers of all patients aged 65 years or older were obtained. To be eligible to participate, subjects had to be active patients of the participating practice site (i.e., received medical service in the past 2 years), be enrolled in both Medicare Part A (hospital) and Part B (physician), be living in the community (i.e., not a resident of a group facility, such as a nursing or rest home), and not be enrolled in a health maintenance organization. Lists obtained from practices were sent to HCFA to determine whether the subjects were enrolled in Medicare Part A and Part B.
Recruitment letters signed by the participating physicians on the practice's letterhead were then sent to eligible patients. One week later, trained interviewers telephoned the subjects to explain the study in more detail, to answer questions, and to set up an appointment for the patient to be interviewed. Baseline interviews were con-ducted at the primary-care practice site where the person was a patient. As patients arrived for their scheduled baseline interviews, they were stratified by age (65-74 and 75 years or more) and gender (male/female), and randomized by strata into the intervention or control groups. Patients were informed of their random group assignment only after they came into the practice for the interview so that participation would not be biased by randomization. Written informed consent was obtained from all randomized patients by a member of the research team. The study protocol was approved by the Human Subjects Committee of the School of Medicine at the University of North Carolina at Chapel Hill.
A total of 1,914 patients were recruited to the intervention (954) or control (960) groups, resulting in a participation rate of 45% of the eligibles. The most frequent reasons given by patients for not participating were that they did not want to take part in research and that it was inconvenient to return for follow-up interviews. Although we have no information on the patients who refused, U.S. census data indicate that the participants were fairly representative of the county populations where the practices were located in terms of their gender and race, but they were slightly older and better educated than those who refused. Neither of these differences attained statistical significance, however. Overall, 82% of the recruited subjects stayed with the study throughout the follow-up.
Data Collection and Measures
The data for the evaluation came from patient encounter forms, a medical chart audit, patient interviews, and Medicare reimbursement records.
Patient Encounter Forms. As mentioned earlier, the nurse/physician assistant and physician completed special preventive-care and health promotion encounter forms for each patient in the intervention group, documenting the services delivered, abnormal findings, and treatment/referral/followup. These forms were used by the practices to bill HCFA and to gather information on physician follow-up of abnormal screening tests. For each test, the nurse or physician indicated whether there was an abnormality, and, for each abnormality, whether "no action" was taken, information or counseling was given, a prescription was provided, a test was ordered, or a referral was made.
Preventive-Care Procedures. The preventive-care package was negotiated with HCFA, and included a mixture of immunizations (influenza vaccination and pneumococcal vaccination), disease screens (clinical breast examination, fecal occult blood test, Pap smear) and function screens (depression, vision, hearing, and incontinence). Although there is only indirect evidence of effectiveness for some of the screening procedures, most guidelines recommend them for older patients. The following screening procedures and criteria for identifying abnormal findings were used.
Riskfor Depression. The short form (Fries J, personal communication, 1986) of the CES-D depression scale16 was used. This scale consists of ten self-rated items, including "I felt lonely,""I felt happy,""I could not get'going,"' "I felt hopeful about the future," and "My sleep was restless." For each item, the respondent is asked to say in the last week whether they felt like this rarely or none of the time (less than 1 day), some or little of the time (1-2 days), occasionally or a moderate amount of time (3-4 days), or all the time (5-7 days). It was administered by the study team on the first patient interview, and in subsequent screening examinations, by the office nurse. Responses are scored 0 to 3, so that the range of scores possible was from 0 to 30; a score greater than 8 was considered positive and meant the patient was at risk for depression.
Incontinence. Urinary incontinence was marked as present if the patient answered "yes"to the question "Do you ever leak or lose urine when you cough, sneeze, or laugh?" or if they answered the question "How often do you have difficulty holding urine until you can get to a toilet?" with a response other than "never."
Hearing. Three screening tests were used to assess hearing difficulties. Two were selfreport: "Can you usually hear and understand what a person says without seeing his face if that person talks in a normal voice to you in a quiet room?" and "Do you often have difficulty understanding people over the telephone?" Patients' hearing was also evaluated using the whisper test: one ear was occluded and the nurse whispered four words 1 to 2 feet behind the other ear. To pass this screening test, a patient had to be able to repeat two of the four whispered words. The test was then repeated for the opposite ear. The patient was considered to have hearing problems if he or she reported difficulty or the whisper test results were abnormal.
Vision. Vision was considered abnormal if a patient had problems "seeing well enough to read ordinary newsprint" or "seeing well enough to recognize a friend across the room." In addition to these self-reports, patients' performance reading the Snellen chart (abnormal = 20/60 or worse in better eye) was used as an objective measure of visual acuity.
Clinical Breast Examination. Abnormal findings were defined as an asymmetrical lump of any size or any consistency.
Fecal Occult Blood Test. Usually, a rectal examination by the physician at the time of the visit was used on a Hemoccult card. Any evidence of blood was counted as positive.
Medical Chart Audit. To determine performance of preventive-care procedures over time, a medical chart audit was conducted on all patients randomized during the first year of the study in three heterogeneous practices. It was not feasible to conduct chart reviews in every practice, so we chose three diverse groups: a threephysician family practice started in the 1940s, serving a predominantly middleclass, retired population; a ten-physician community health center, serving a predominantly urban, black population; and a six-physician suburban internal medicine practice, representing five subspecialties and serving a predominantly white, middleclass population. These three practices represented the spectrum of practices in the study. There had initially also been a group of patients that received only immunizations and screenings (no health promotion), and patients randomized into this group within the first year of the study were included in the medical chart audit. Because only a small number of patients were randomized into this group, the rest of the analyses in this study exclude them.
Chart audits were conducted by two trained research assistants, blinded to the research question, with written coding criteria and unannounced periodic spot checks by the investigators throughout the study. Of 458 patients eligible for chart audit, charts were located and reviewed for 455 (231 intervention, 224 control).
All charts were reviewed for whether any of 11 preventive activities (pneumococcal and influenza vaccinations, clinical breast examination, Pap smear, vision and hearing screening, screening for depression and urinary incontinence, the fecal occult blood test, mammography, and serum cholesterol) had been performed during the review periods. Credit was given for "performance" if the activity had been offered or discussed, independent of whether it had been completed. The first nine of these activities had been included in the study intervention, whereas the last two (mammography and cholesterol) had not. The last two were included in the chart audit so that we could determine whether a "halo effect" had occurred: that is, did the intervention carry over to other preventive procedures, even those not included in the intervention? Each chart was reviewed for two time periods, defined by the date on which the patient was randomized into the study. The first period was from the randomization date (RD) backward for 24 months, whereas the second was from that date forward to the end of 1988 (a variable period of 14-26 months, but equal in the aggregate between intervention and control groups). Because the second review period was usually shorter than the first, it was expected that, in the absence of any intervention effect, the overall performance of these procedures might well appear lower in the second period than in the first. Over the period of the study, there were more deaths in the intervention group (8.5%) than the control group (7.7%), but this difference, analyzed by regression and by comparison of survival curves, was not statistically significant. The deaths were highly correlated with baseline health status. Those who died incurred very high costs as well as zero scores on the follow-up QWB scale, sufficient to affect the results of the analysis. Therefore, we analyzed data both for the full sample and for the survivors alone.
Costs. When displayed in graphic form, the cumulative Medicare costs for study subjects exhibited a steep upward trend in all cases because of the high rates of inflation in medical care costs during the period for which costs were collected, as well as the aging of the participants, which generally led to greater utilization of services.
With so few data points (covering 2 years before and only 3 years after RD), timeseries analysis and quarterly comparisons were not feasible. Thus, we pooled the 3-years data on post-RD costs and used that as the basis for comparing cost and utilization data between the intervention group and the control group.
We used regression analysis to determine the impact of the intervention adjusted for the various demographic and baseline measures on the reimbursed costs of the two groups. Because the distribution of Medicare costs (disbursements) was bimodal and nonnormal, we used four-stage probit models of the type developed for The RAND Corporation Health Insurance Experiment.21,22 Because of the skewness introduced by very large payments (often associated with the final year of life) in the right-hand tail and many zeros representing nonusers in the left-hand tail, we used:
1. Probit models for the total study period of the probability of Medicare reimbursement and the probability of at least one inpatient stay. 2. Linear regression equations of the logarithms of total period reimbursements for outpatient-only users and users of any inpatient services. The logarithmic transformation yields more nearly symmetric and roughly normal error distributions. An example of these regressions is shown in Table 8 . 3. A "smearing factor"22 to retransform the latter two estimates by multiplying the sample average of the exponentiated least squares residuals times the exponentiated estimates of the estimated conditional reimbursement for outpatient-only eligibles and inpatient users. The smearing factor tends to smooth out or normalize the distribution of reimbursements.
All charges and reimbursements are reported in current dollars. This is because charges were rising at one rate during this period and the Medicare Parts A and B reimbursements at two other rates, whereas the fees paid by HCFA for this intervention under the Medicare waiver were arbitrarily held to a 4.27% rate of increase over the same period. We did deflate the Medicare Part A reimbursements for intervention and control groups by changes in the Hospital and Related Services component of the Consumer Price Index (CPI) over this period, and found that the difference between these sets of charges would have been reduced by 19.99% over the 3-year period. The comparable reduction in savings using the Medical Care component of the CPI would have been 17.5%.
Results
Sample Characteristics and Participation Rates
As indicated in Table 3 , most of the sample was younger than 75 years of age (60.0%), women (61.1%), married (57.0%), and white (71.2%). The nonwhite subjects included blacks (28.4%) and other racial groups (0.4%). Nearly two thirds (65%) of the sample had a high school education or less, whereas half (49.9%) had incomes of less than $10,000. Only 34.3% rated their health as being fair or poor. Only 12% of the intervention group did not receive any clinical screening, 36% received one or two screenings, and 52% received three or four; 13% did not receive any health promotion service, 38% received one to four services, and 49% received five to eight services. At the 2-year follow-up, there were no differences between intervention and control groups in smoking rates, alcohol consumption, weight reduction, medication use, or in having a living will.
Eighty-two percent of the patients completed both baseline and follow-up interviews. Of the 347 patients lost to follow-up, 30.8% refused the second interview, 46.1% died, and the remaining 23.1% either dropped out of the study owing to transportation problems, moved, or could not be located. Patients lost to follow-up were somewhat older and had less education than patients who completed both interviews, and they were more likely to be men and unmarried, but the differences were quite small. There was no difference in response rates for blacks or whites, or for intervention and control groups.
Performance of Preventive Activities
Preventive Care. In the three practices in which we conducted chart audits, there was little difference in performance between intervention and control groups for any pre-ventive activity (Figure 1 ) in the time period before the RD. After RD, however, performance was much higher in the intervention than the control group for the nine intervention activities (P < 0.001), but not for the two nonintervention activities. (Screening tests for depression, incontinence, vision, and hearing were partly done by the research staff, and thus increased performance for these procedures was not the result of the intervention.) These data indicate a large effect of the study intervention on the performance of preventive activities within the three heterogeneous practices studied. There were no differences in these findings by practice; the effect was clearly apparent in each. To explore the issues around lack of physician follow-up, we conducted semistructured interviews after the study was completed with 24 of the 30 physicians who had participated in the study. These physicians believed that most people with vision and hearing problems were already known and seeing appropriate specialists, and that some positive screens for depression were false-positive results. They also doubted that all of the positive screens for incontinence, visual problems, or hearing problems were severe enough to require treatment. They believed that patients would likely tell them when the problems became serious enough to treat. Finally, many of the physicians believed that patients could not afford and would not wear hearing aids if they were found to have hearing impairment.
There was no single issue that was a barrier for all procedures. Instead, the cited barriers were procedure-specific. Yet, lack of follow-up appeared to be universal for the function screens.
Another issue discussed with physicians, however, was a potential barrier for follow- perceived quality of life. Over 75% of the sample had scores of 72 or higher. For PQOL, the analyses reported for QWB were repeated, substituting PQOL at follow-up for the dependent variable, and adjusting for baseline PQOL. Here, the intervention group value was significantly higher (P < 0.01) on the adjusted mean PQOL than the control group, but the difference was rather small (Table 6 , Model 2).
The same analysis was performed with SPHS as the outcome measure. At baseline, the distribution of SPHS scores in the current study was excellent/very good-36.8%, good-28.9%, fair/poor-34.3%. The overall mean was 3.2 and the standard deviation was 1.2. At follow-up, the mean SPHS score for the intervention group was slightly better (P < 0.01) than the mean SPHS score for the control group (Table 6 , Model 3).
Utilization and Cost Outcomes
The cost data show that the 3-year average cumulative post-RD actual Medicare costs (reimbursements) for the intervention group were less than those of the control group and greater than the direct cost to Medicare (Table 7) , despite the fact that in than the control group. The magnitude of the 2-year period before randomization, the the post-RD difference, estimated a variety members of the intervention group reof ways, was somewhat higher than the cost ported higher health care utilization and of the intervention ( Table 7) . Because of the showed higher average cumulative costs nonnormal nature of cost data, it was not The difference in the probability of any hospital utilization (having Part A charges) over 3 years was significantly lower for the intervention group (P < 0.02) and was the primary source of cost savings for the intervention group. The raw data show that an average investment of $294 (the maximum amount spent per patient was $313) spread over 3 years yielded a difference of $503 evident over the same 3 years, most of which appeared during the latter half of the period. Whether the savings ($190 over 3 years) continued after the intervention stopped remains to be studied.
We were concerned that the differences in the demographics and baseline status of the two samples, and variations in the periods of exposure of the participants due to the shortening of the project and the deaths of participants (90 in the control group and 98 in the intervention group) might confound cost comparisons. Therefore, when we estimated the costs using the probit model (Tables 8 and 9 ), we also adjusted for demographic and baseline differences.
In addition to the size and significance of these costs and utilization differences, we also studied the timing of the savings. Analyses indicate that trend lines for cumulative costs and utilization begin to diverge 12 to 24 months into the intervention and continue to diverge throughout the remainder of the follow-up period. One nagging question is "How long will those effects continue?"The divergence of the hospital costs is much more pronounced than that of physician costs. This is not a surprising timing pattern, because many of those in both the intervention and control groups were not regular users of medical care, and the costs of treating existing medical problems uncovered by bringing the intervention group in for clinical screening would mask the preventive-care cost savings over the first year or two. 
Discussion
We found that a financial and office system intervention in ten primary-care practices dramatically increased the percentage of a physician-recruited, self-selected group of patients receiving preventive care. Although the intervention groups were a small subgroup of practice patients, increasing preventive care to this degree among even a selected group is an impressive achievement. Clearly, it is possible to implement preventive care for a large percentage of eligible patients even in busy primary care practices.
Although part of the apparent increase in performance may have been the result of improved charting (the project provided a chart form to record performance for patients in the intervention group), it is unlikely that such high posttest performance levels and such marked changes from pretest levels can be completely explained by charting alone. Improved charting may also be considered improved care, because it allows more appropriate decisions about future preventive procedures.
Because the intervention was multifaceted, involving both financial reimbursement and office systems factors, it is not clear whether increased performance was a result of a part or all of the intervention. The fact that there was a larger increase in pneumococcal vaccination (a procedure that was reimbursed by Medicare even before the study) than influenza vaccination (a procedure not reimbursed at this time) argues that the effect was not entirely produced by free care. The office systems component of the intervention likely had an important effect.
The fact that there was as great an increase in physical examination procedures (usually performed by physicians) as in immunizations (usually performed by nurses) argues that the effect was not produced entirely by nurses carrying out preventive care. That there was no parallel increase in mammography or cholesterol screening, tests not part of the interventions, indicates that there was no generalized increased interest in preventive care. It seems likely that the intervention as a whole created an organized "system" that effectively increased performance of the package of procedures in the practices.
We also found that only a small percentage of patients with abnormal functional screening test results received follow-up evaluation and treatment. There are several possible explanations for this. The abnormalities may already have been known to physicians and patients, and thus did not require further care. Interviews with participating physicians after the project was concluded indicated that at least some tended to ignore results from the functional tests because they perceived that the problem was trivial, or that they believed there is a lack of proven efficacy for further treatment. Although there are questions about the efficacy of screening for many conditions, a growing literature considers the problems in this package potentially treatable. The U.S. Preventive Services Task Force supports screening elderly patients for vision and hearing, and the Agency for Health Care Policy and Research has published guidelines on screening for depression and incontinence. It is likely that at least some patients would benefit from followup evaluation and treatment of these abnormal functional screening test results. 23 It is unlikely that financial reasons prevented follow-up, because all participants had Medicare, which has always reimbursed for diagnostic or treatment services. We also doubt that patient refusal of follow-up played a significant role, because patient participants tended to be interested in preventive care.
Another possible explanation for the lack of follow-up of abnormal functional test results is that the office system that so successfully performed preventive services included no component to follow up abnormalities. The extremely low rate of follow-up for functional tests argues that this lack of a systematic approach to follow-up was likely a factor. Research on implementation of preventive services in primary-care practices should examine the extent to which abnormalities receive follow-up.
Targeted health behaviors, such as cigarette smoking and exercise, also did not change more in the intervention than in the control groups. The health promotion part of the intervention, however, involved primarily risk assessment and referral for counseling. Thus, this was not a true test of scientifically based health promotion counseling within medical practices.
We also found that health-related quality of life, indicated by several global measures, did not improve in the groups receiving increased preventive care, although there was a slight trend in this direction among survivors. It is likely that lack of physician followup of screening abnormalities and lack of actual in-office counseling made improved quality of life unlikely in this setting. Further evaluation of the efficacy of functional screening tests to improve quality of life should be a high priority.
An intriguing part of our results is the indication that the addition of a preventivecare benefit to Medicare could be either cost neutral or even (in the long run) cost saving. Only HCFA costs were considered in this study; savings in out-of-pocket health care costs of the elderly could amount to an additional several hundred dollars per year (excluding insurance costs). It is unclear what effect more aggressive follow-up of abnormal functional screening tests and increased reinforcement of counseling messages would have had on long-term cost data. The possibility, however, that increasing preventive care might not result in large long-term cost increases (as had been expected) bears further research.
These results should not be seen as indicating that increased preventive care for older adults does not lead to improvement in quality of life. Larger numbers of patients, better preventive-care packages, ensured follow-up of abnormal screening results, a longer intervention period, and continued surveillance of study patients over a longer time would have been necessary to answer this question. Our findings, however, do call into question many key assumptions of health care reform proposals about the cost effectiveness of preventive care for elderly people, and they suggest fruitful avenues for further research. Five additional HCFA Medicare demonstrations15 that were mandated by the U.S. Congress are in the field. Results from these studies may replicate and extend the current findings.
We conclude that Medicare reimbursement for preventive care and office systems changes can dramatically increase performance of preventive procedures, but, without a systematic approach to follow-up, does not guarantee patient benefit. Medicare reimbursement for preventive care alone is unlikely to change either the patient's quality of life or costs to the Medicare program in any substantial way. Simple office systems changes within practices of the type implemented in this study will increase performance, but again, they will not significantly affect costs or quality of life. Expanded office systems that include patient follow-up have the potential for affecting both costs and quality of life, but the balance between further costs and benefits is as yet uncertain.
